Cablivi (caplacizumab) approved in Europe for adults with aTTP

Read more

Evox Therapeutics completes £35.5 million Series B financing

Read more

Bayer Receives FDA Approval for Jivi, New Hemophilia A Treatment With Step-Wise Prophylaxis Dosing Regimen

Read more

Tetraphase Announces FDA Approval of XERAVA (Eravacycline) for cIAI

Read more

PCI Expands Cold Chain Infrastructure with Dedicated -40°C Facility

Read more

Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington’s disease

Read more

Regen BioPharma Reports Success of its NR2F6 Small Molecule Screening Program for Treating Autoimmune Diseases

Read more

CRF Health Partners Innovative US Biotech with TrialMax eCOA Solution for Phase III Prostate Oncology Study

Read more

Longeveron Appoints Arin Maercks Chief Commercial Officer

Read more

Alnylam Receives Approval of ONPATTRO (patisiran) in Europe

Read more